BioCentury
ARTICLE | Company News

Arctic Partners, Opko deal

January 30, 2012 8:00 AM UTC

Opko acquired exclusive rights to two kallikrein family biomarkers from Arctic Partners. Opko said it will develop a prostate cancer screening test using the biomarkers and prostate specific antigen ...